Current Opinion in HIV and AIDS was launched in 2006. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of HIV and AIDS are divided into six sections that are reviewed once a year. Each section is assigned Section Editors, leading authorities in the area, who identify the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Carolyn Williams' has studied clinical outcomes for HIV patients since the beginning of the therapy era to today's highly effective antiretroviral therapy. She has specialized in research in longitudinal cohorts and, in addition to researching long term clinical outcomes and their predictors, she has engaged in work in modeling and implementation science. She was the project scientist for the two male circumcision clinical trials funded by the NIH in Kenya and Uganda. She has been a member of the Epidemiology Branch at the NIAID Division of AIDS since February, 2000 and became Chief in 2003.
Dr Williams' currently oversees a range of clinical epidemiology projects including the Multicenter AIDS Cohort Study (MACS), a study of men who have sex with men in the US, the Women's Interagency HIV Study (WIHS), a study of women with or at risk of HIV, and the International epidemiology Databases to Evaluate AIDS (IeDEA), a large collaborative clinical database consortium to advance our understanding of the global HIV epidemic. This research includes support for novel statistical methods. Prior to coming to the federal government, she worked for the Baltimore City Health Department on the CDC HIV Seroprevalence surveys. Dr Williams is an alumnus of Wesleyan University, USA, (Biochemistry 1986), Uniformed Services University (MPH 1991) and Johns Hopkins University School of Hygiene and Public Health (PhD 1999) In addition, she is an Editor of the contributed graduate textbook Infectious Disease Epidemiology: Theory and Practice, Second Edition, Nelson and Williams Editors, 2005.
Matthew Law is Head of the Biostatistics and Databases Program at the Kirby Institute for Infection and Immunity in Society, UNSW, Sydney, Australia. He has broad research interests in randomized clinical trials, cohort and linkage studies, and mathematical modeling of HIV, HCV and sexually transmissible infections. He has a particular interest in observational cohort studies of HIV-infected patients, and sits on the Steering Committees of the Australian HIV Observational Database (AHOD), the Data Collection on Adverse events of Anti-HIV Drugs Study (D:A:D), the TREAT Asia HIV Observational Databases (TAHOD), and the TREAT Asia Paediatric HIV Observational Database (TApHOD).
François Dabis, MD, is Professor of Epidemiology at the School of Public Health (ISPED) of the University Bordeaux Segalen, in Bordeaux, France. Dr Dabis has 25 years of experience in research on HIV epidemiology and global health. He has been leading the HIV research team within ISPED since 2001. His scientific interests are: public health challenges of HIV prevention and care; prevention of mother-to-child transmission in Africa; cohort studies of antiretroviral-treated adults and children in France and West Africa; and, more generally, operational research on HIV programs in resource-limited settings.
François Dabis is the Chair of the Coordinated Action no. 12 of the French Agency for Research on HIV/AIDS and Viral Hepatitis (ANRS), in charge of the scientific agenda of the Agency in lower-income countries. He is also the Chair of the Scientific Committee of the Institut National de la Veille Sanitaire (French CDC) since 2003. His scientific productivity can be seen through more than 450 publications in peer-reviewed journals and book chapters and his contribution to the Editorial Board of two leading journals in infectious diseases: AIDS and the Journal of Acquired Immune Deficiency Syndromes (JAIDS).